explore -WSS

explore

author：knowledge 2025-08-23 04:58:07 - browse：37

Boxes of Ozempic photo illustration. -- health coverage from STAT — Mario Tama/Getty Images

LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney disease or dying from kidney or heart complications, the company said Tuesday, adding to the evidence the wildly popular drug has broader health benefits for patients beyond addressing their diabetes.

Overall, Ozempic lowered the risk of progression of patients’ kidney disease and of related health events by 24% versus placebo, according to the topline results. The company, which will present full data from the study later this year, said it would file for an expanded approval of Ozempic based on the data in both the U.S. and Europe.

The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the study’s goals. Still, the results provide an important data point for Novo both as its medicines face increasing competition and as it tries to get more insurers to cover its related obesity drug Wegovy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Why doctors need education on FDA device approval process

hotspot

WSS

'The boss' wants server deleted: New allegations emerge in Trump indictment

Biotech venture capitalists face new demands from investors

Independent physicians launch a new lobbying group

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

An outrageous hospital charge: I paid $710 for an hour of babysitting

Interest rates are at a 22

knowledge

explore

entertainment

Bright Health sells Medicare Advantage business to Molina

As the dark side of IVF slowly comes into focus, even more transparency is needed

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Medical leaders decry Supreme Court decision on affirmative action

CDC: Cases of alpha

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Think you might have Covid

Wildfire smoke exposes gaps in outdoor worker protections

Dewpoint Therapeutics lays off staff after losing partnerships

knowledge

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Ending health disparities requires full federal government, panel says

Interest rates are at a 22

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Alexander Hamilton and the argument for universal insurance

Prior authorization will have to move faster under new Biden rule

hotspot

hotspot

knowledge

entertainment